✦ LIBER ✦

A phase I clinical trial of Ad5/3-Δ24, a novel serotype-chimeric, infectivity-enhanced, conditionally-replicative adenovirus (CRAd), in patients with recurrent ovarian cancer

✍ Scribed by Kim, Kenneth H.; Dmitriev, Igor P.; Saddekni, Souheil; Kashentseva, Elena A.; Harris, Raymond D.; Aurigemma, Rosemarie; Bae, Sejong; Singh, Karan P.; Siegal, Gene P.; Curiel, David T.; Alvarez, Ronald D.

Book ID: 120456652
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 608 KB
Volume: 130
Category: Article
ISSN: 0090-8258
DOI: 10.1016/j.ygyno.2013.06.003

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A New Generation of Serotype Chimeric In

A New Generation of Serotype Chimeric Infectivity-Enhanced Conditionally Replicative Adenovirals: The Safety Profile of Ad5/3-Δ24 in Advance of a Phase I Clinical Trial in Ovarian Cancer Patients

✍ Kim, Kenneth H.; Ryan, Michael J.; Estep, James E.; Miniard, Brock M.; Rudge, Th 📂 Article 📅 2011 🏛 Mary Ann Liebert 🌐 English ⚖ 490 KB

Identifying the safety profile of a nove

Identifying the safety profile of a novel infectivity-enhanced conditionally replicative adenovirus, Ad5-Δ24-RGD, in anticipation of a phase I trial for recurrent ovarian cancer

✍ John G. Page; Baohong Tian; Karen Schweikart; Joseph Tomaszewski; Ray Harris; Tr 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 245 KB

A phase I clinical trial of a novel infe

A phase I clinical trial of a novel infectivity-enhanced suicide gene adenovirus with gene transfer imaging capacity in patients with recurrent gynecologic cancer

✍ K. Kim; M. Wang; M. Barnes; J. O'Malley; Z. You; M. Preuss; G. Siegal; K. Zinn; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 139 KB